+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms

Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms

Cns Spectrums 13(3 Suppl 4): 18-25

Psychosis in Parkinson's disease refers to a combination of hallucinations and delusions occurring with a clear sensorium and a chronic course. Hallucinations may involve several sensory modalities. Complex visual hallucinations are the most common type. "Minor" hallucinatory phenomena are frequently present and include visual illusions, passage hallucinations, and sense of presence. Insight may be lost in patients with cognitive impairment. Delusions of a paranoid type are more rare than hallucinations. Both hallucinations and delusions are more frequent in Parkinson's disease patients with dementia. Pathogenesis involves complex and probably multifactorial mechanisms, including pharmacologic (dopaminergic treatment and others) and disease-related factors.

(PDF emailed within 0-6 h: $19.90)

Accession: 055275696

Download citation: RISBibTeXText

PMID: 18323763

DOI: 10.1017/s1092852900017284

Related references

Prevalence, associated factors and phenomenology of psychosis in patients with Parkinson's disease. Gaceta Medica de Mexico 151(2): 169-175, 2015

Current Understanding of Psychosis in Parkinson's Disease. Current Psychiatry Reports 18(10): 97-97, 2016

Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments. Clinical Neuropharmacology 28(5): 215-219, 2005

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 123: 733-745, 2000

Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management. Drugs & Aging 33(12): 855-863, 2016

Hallucinations in Parkinson's disease. prevalence, phenomenology and risk factors. Fenelon G* mahieux F, huon R, Ziegler M. Brain 2000;123:733-745. American Journal of Ophthalmology 130(2): 261-262, 2000

Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Memorias do Instituto Oswaldo Cruz 104 Suppl 1: 152-158, 2010

Current understanding of the pathophysiologic mechanisms of canine atopic dermatitis. Journal of the American Veterinary Medical Association 241(2): 194-207, 2012

New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins. Expert Review of Neurotherapeutics 7(12): 1731-1750, 2007

Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. Journal of Neural Transmission 107(1): 59-71, Jan 26, 2000

Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. European Respiratory Journal 41(2): 462-468, 2013

Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates. Rinsho Shinkeigaku 45(1): 1-5, 2005

The frequency and associated risk factors for dementia in patients with Parkinson's disease. Archives of Neurology 52(7): 695-701, 1995

Frequency, reasons, and risk factors of entacapone discontinuation in Parkinson disease. Clinical Neuropharmacology 27(3): 119-123, 2004